Nurotron Biotechnology

About:

Hangzhou Nurotron Biotechnology is a high-tech enterprise providing nerve electronic products.

Website: http://nurotron.com

Twitter/X: nurotron

Top Investors: Qiming Venture Partners, Kleiner Perkins, DT Capital Partners, GL Ventures LLC, Superstring Capital

Description:

Hangzhou Nurotron Biotechnology Co., Ltd., (诺尔康神经电子科技) is a high-tech enterprise providing nerve electronic products. The company is mainly involved in the R&D of multipath manual electrical cochlea systems, nationalization and clinical application of auditory brainstem implant equipment, strategy and technology enhancement of home-grown manual cochlea, and more. The company’s headquarters and production base are located in Hangzhou, China, and its R&D center is located in California, USA.

Total Funding Amount:

$48.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2006-01-01

Contact Email:

info(AT)nurotron.com

Founders:

Fan-Gang Zeng, Fangping Li

Number of Employees:

11-50

Last Funding Date:

2020-10-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai